This page contains a Flash digital edition of a book.
Figure 9 Employee Absenteeism After Implementing Drug Testing


Figure 10 Workers’ Compensation rates after Implementation of Drug Testing


chronic high absenteeism. One of the early findings of implementation of drug testing programs was the decrease in absenteeism (14). There are many explanations as why this benefit may be caused by a drug testing program but the classic explanation is a better quality of employee who does not “call in sick” on Mondays. Employees that are using illicit drugs or abusing prescription drugs are less productive, tend to miss work more often, may steal from the company and are prone to more accidents (14,15). The proportion of companies reporting low absenteeism rates (0–15%) increased from 91% to 96% after implementing drug testing programs. This was one of the questions in the survey that had one of the lowest responses (n=162 and n=218 respectively) and suggests that this is one measurement that compa- nies have a hard time correlating to implementation of a drug test when their absentee numbers are relatively low. However, when the absenteeism of the company was greater than 15%, the implementation of a drug testing program showed a reduction in absentee- ism from 9% to 4% (see Figure 9). This strongly suggests that when absenteeism is greater than 15%, a significant portion of this absenteeism is related to drug use/abuse and that the implementation of a drug testing program significantly impacts absenteeism. Several state and private insurance


companies provide decreased workers’ compensation premium rates for com- panies who have a drug testing program as they know it will decrease accidents and their costs associated with claims. This is especially true in companies that have high rates of workers’ compensation claims, greater than 6%. The study par- ticipants reported a decrease in workers’ compensation incidence rates from 14% to 6% (among organizations with work- er’s compensation incidence rates greater


16 datia focus spring 2012


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62